SPC536
Sebetralstat eða lyfjafræðilega viðunandi salt eða lausnarsamband þar af / Sebetralstat or a pharmaceutically acceptable salt or solvate thereof
Status:
UmsóknApplication date:
12.1.2026Application published:
11.2.2026
Medicine name:
EkterlyMedicine for children:
No
Timeline
Today
12.1.2026Application
11.2.2026Publication
Marketing license
Foreign authorization number:
EU/1/25/1975Date:
17.9.2025
Owner
Name:
Kalvista Pharmaceuticals LimitedAddress:
Porton Science Park Bybrook Road, Porton Down, Wiltshire SP4 0BF GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3224256